Analytical Data
-
基因名
ctfB
- Application
-
别名
ctfB；Acetoacetyl-CoA:acetate/butyrate CoA-transferase beta subunit
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P23673
-
表达区间
1-221aa
-
氨基酸序列
MINDKNLAKEIIAKRVARELKNGQLVNLGVGLPTMVADYIPKNFKITFQSENGIVGMGASPKINEADKDVVNAGGDYTTVLPDGTFFDSSVSFSLIRGGHVDVTVLGALQVDEKGNIANWIVPGKMLSGMGGAMDLVNGAKKVIIAMRHTNKGQPKILKKCTLPLTAKSQANLIVTELGVIEVINDGLLLTEINKNTTIDEIRSLTAADLLISNELRPMAV
-
分子量
30.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of CTFB (C-terminal-binding protein) recombinant proteins has gained significant attention due to their crucial roles in various biological processes, including gene regulation, cellular signaling, and development. CTFB proteins function as transcriptional co-repressors, interacting with a variety of transcription factors and mediating the repression of target genes. Their involvement in critical pathways has implications for understanding developmental disorders and diseases such as cancer. The ability to produce recombinant CTFB proteins in vitro allows researchers to investigate their structural properties, functional mechanisms, and interactions with other molecular partners. Moreover, studying these proteins can shed light on the regulatory networks in which they operate and open avenues for therapeutic interventions. The advancement of recombinant DNA technology and protein expression systems has made it feasible to generate large quantities of CTFB proteins, facilitating biochemical assays, structural studies, and potential drug discovery efforts. Understanding the complexities of CTFB function could lead to novel insights into cellular regulation and contribute to the development of targeted therapies for diseases associated with CTFB dysregulation.
